The company has hundreds of clinical trials underway at major medical centers, exploring compounds for hematological and solid tumor cancers, as well as inflammatory diseases like psoriasis and psoriatic arthritis. Celgene's focus on gene and protein regulation allows them to provide patients with access to innovative, disease-altering therapies, supported by industry-leading programs that prioritize patient needs. The company is headquartered in New Jersey and employs over 7,000 people across more than 60 countries.